Tuesday, March 16, 2010 10:41:29 AM
if Euan Thomson hasd not F'd it up!
Handwriting on the wall:
Varian Medical Systems (NYSE: VAR) today announced that it has appointed John R. Adler, Jr., M.D., as Vice President and Chief of New Clinical Applications for the company. Dr. Adler, a renowned neurosurgeon, professor of Neurosurgery and Radiation Oncology at Stanford University, and past CEO, chairman and founder of Accuray, Inc., will be joining Varian to play a key role in guiding the development of Varian's next-generation clinical products and applications for radiosurgery and other new treatments.
"John Adler brings a unique combination of strengths to the Varian team, including expertise in radiosurgery together with an impressive record of success as a clinical researcher, innovator, and entrepreneur," said Tim Guertin, president and CEO of Varian. "He is a respected clinician who will have a strong voice in the development of Varian's next-generation surgical products."
"I welcome the opportunity to join Varian where I will have a broad technological platform and management's enthusiastic commitment to continue shaping the still-emerging field of radiosurgery and to enhance clinical offerings for radiotherapy," said Dr. Adler. "Varian is already among the leaders in radiosurgery and I am convinced that the future will bring even better technology and a broadening array of clinical applications for precision radiation that can attack more and more diseases and help save the lives of untold numbers of patients."
Dr. Adler, who joins Varian effective April 5, will report to Guertin and be a member of the CEO staff. He will represent Varian at medical meetings and partner with radiation oncologists and surgeons to develop products and clinical approaches that expand the applications for and improve the outcomes of radiosurgery. His responsibilities include working with the medical community to improve the effectiveness and efficiency of Varian clinical products through best-in-class designs, techniques, and processes.
Varian has installed more than 170 dedicated surgical units and another 1,000 units capable of both radiotherapy and radiosurgery among more than 5,800 installations operating around the world.
Dr. Adler, 55, was the Founder, CEO, Chief Medical Officer, Chairman and Board Member for Accuray (Nasdaq: ARAY), where he served from 1991 until 2009. He also served as a Professor of Neurosurgery and Radiation Oncology at Stanford University from 1987 through 2010. In his most recent position at Stanford, Dr. Adler served as the Dorothy and TK Chan Professor of Neurosurgery. Prior to joining Stanford, Dr. Adler did a neurosurgical residency at the Brigham & Women's, Children's and Massachusetts General Hospitals in Boston. His training included a one year fellowship with Lars Leksell at the Karolinska Institute, the father of radiosurgery.
He serves on the editorial boards of the Neurosurgery, Technology in Cancer Research & Treatment, Journal of Image-Guided Surgery, Chinese Journal of Clinical Oncology,and functions as editor in chief of peerEmed.com. Dr. Adler previously served on the editorial boards of Stroke and Journal of Radiosurgery.
Dr. Adler is currently president-emeritus and chairman of the CyberKnife Society, an organization he founded, and a member of the Congress of Neurological Surgeons, the American Association of Neurological Surgeons, the Western Neurosurgical Society, the John W. Hanbery Society, the International Society of Stereotactic Radiosurgery, and the American Society of Stereotactic and Functional Neurosurgery.
Dr. Adler graduated magna cum laude from Harvard College in 1976 and from Harvard Medical School in 1980.
Note to editors: High resolution photos are available in the Varian online newsroom.
Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 5,000 people who are located at manufacturing sites in North America, Europe, and China and approximately 79 sales and support offices around the world. For more information, visit http://www.varian.com. VMS122
FOR INFORMATION CONTACT:
Spencer Sias, (650) 424-5782
spencer.sias@varian.com
SOURCE Varian Medical Systems, Inc.
"I call investing the greatest business in the world because you never have to swing... All day you wait for the pitch you like,... The problem when you're a money manager is that your fans keep yelling, 'Swing. you bum!'"
W. Buffett
Recent ARAY News
- Accuray Reports Fiscal 2024 Third Quarter Financial Results • PR Newswire (US) • 05/01/2024 08:06:00 PM
- Accuray Showcases Advances in Radiation Therapy Solutions Designed to Improve the Cancer Treatment Experience at ESTRO 2024 • PR Newswire (US) • 04/25/2024 11:35:00 AM
- Accuray Expands Global Training Center Network With Opening of New Facility in Genolier, Switzerland • PR Newswire (US) • 04/18/2024 11:35:00 AM
- Accuray to Report Third Quarter Fiscal 2024 Financial Results on May 1, 2024 • PR Newswire (US) • 04/17/2024 08:05:00 PM
- New Data from Two Clinical Studies Indicate High-Risk and Recurrent Prostate Cancers Can be Effectively Treated in 5 Days Using the Accuray CyberKnife® System • PR Newswire (US) • 03/26/2024 11:35:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:15:22 PM
- Accuray Incorporated to Speak at 36th Annual Roth Conference • PR Newswire (US) • 03/04/2024 09:30:00 PM
- Accuray Incorporated to Speak at Oppenheimer 34th Annual Healthcare MedTech & Services Conference • PR Newswire (US) • 02/27/2024 10:30:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 04:19:22 PM
- Quebec Cancer Center is First in Canada to Treat Cancer Patients Using the Accuray Radixact® System • PR Newswire (US) • 02/13/2024 12:35:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 08:01:38 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/07/2024 09:15:46 PM
- Accuray to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference • PR Newswire (US) • 02/05/2024 10:30:00 PM
- Accuray Reports Fiscal 2024 Second Quarter Financial Results • PR Newswire (US) • 01/31/2024 09:06:00 PM
- Providence Swedish Radiosurgery Center in Seattle Invests in Second Accuray CyberKnife® System, a Robotic Delivery Device That Makes Extremely Precise Radiation Treatments Possible in 1-5 Sessions • PR Newswire (US) • 01/25/2024 12:35:00 PM
- Accuray to Report Second Quarter Fiscal 2024 Financial Results on January 31, 2024 • PR Newswire (US) • 01/16/2024 10:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 09:15:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 09:15:14 PM
- Accuray Initiates Sales of the VitalHold™ Solution in Japan, Supporting Surface-guided Radiation Therapy on the Radixact® System • PR Newswire (US) • 12/05/2023 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 01:51:44 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 01:50:50 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 01:50:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 01:50:44 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 01:50:41 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 01:50:37 AM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM